Total Payments
$14,977
2024 Payments
$2,869
Companies
45
Transactions
434
Medicare Patients
5,052
Medicare Billing
$633,236
Payment Breakdown by Category
Food & Beverage$14,828 (99.0%)
Education$149.66 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,828 | 429 | 99.0% |
| Education | $149.66 | 5 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $3,005 | 55 | $0 (2024) |
| Boston Scientific Corporation | $1,849 | 38 | $0 (2024) |
| Abbott Laboratories | $949.61 | 14 | $0 (2022) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $892.74 | 41 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $861.79 | 28 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $835.44 | 26 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $721.53 | 29 | $0 (2024) |
| PFIZER INC. | $668.81 | 27 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $538.67 | 23 | $0 (2024) |
| Medtronic Vascular, Inc. | $525.85 | 18 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,869 | 97 | Medtronic, Inc. ($515.02) |
| 2023 | $2,662 | 90 | Medtronic, Inc. ($1,007) |
| 2022 | $2,493 | 75 | Medtronic, Inc. ($927.03) |
| 2021 | $1,863 | 56 | Medtronic, Inc. ($556.36) |
| 2020 | $766.60 | 41 | Medtronic Vascular, Inc. ($155.78) |
| 2019 | $1,497 | 29 | PFIZER INC. ($323.02) |
| 2018 | $1,245 | 23 | Janssen Pharmaceuticals, Inc ($260.67) |
| 2017 | $1,582 | 23 | Abbott Laboratories ($533.53) |
All Payment Transactions
434 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $52.15 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $25.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/10/2024 | Vital Connect, Inc | VITALPATCH RTM (Device) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: CARDIOLOGY | ||||||
| 12/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: DIABETES | ||||||
| 12/04/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $13.45 | General |
| Category: Coronary | ||||||
| 12/03/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Cardiology | ||||||
| 11/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: DIABETES | ||||||
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.90 | General |
| Category: Cardiovascular | ||||||
| 11/05/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $34.66 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/31/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: Lithoplasty | ||||||
| 10/29/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.99 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: DIABETES | ||||||
| 10/14/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/07/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/04/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.32 | General |
| Category: Cardiovascular | ||||||
| 10/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/26/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 09/24/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: Lithoplasty | ||||||
| 09/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/18/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $26.74 | General |
| Category: Coronary | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/16/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $18.45 | General |
| Category: Heart Failure and Hypertension | ||||||
| 09/13/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/11/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.86 | General |
| 09/06/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.17 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,222 | 1,908 | $381,097 | $124,979 |
| 2022 | 22 | 1,392 | 2,387 | $558,849 | $173,187 |
| 2021 | 20 | 1,296 | 2,470 | $522,422 | $173,228 |
| 2020 | 19 | 1,142 | 2,328 | $486,957 | $161,843 |
Total Patients
5,052
Total Services
9,093
Medicare Billing
$633,236
Procedure Codes
89
All Medicare Procedures & Services
89 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 158 | 645 | $98,685 | $42,991 | 43.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 118 | 244 | $37,332 | $16,463 | 44.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 124 | 143 | $42,900 | $15,680 | 36.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 62 | 67 | $50,183 | $10,124 | 20.2% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 11 | 16 | $36,528 | $8,593 | 23.5% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 29 | 29 | $35,902 | $6,166 | 17.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 104 | 107 | $21,919 | $5,914 | 27.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 39 | 40 | $8,000 | $3,849 | 48.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $9,308 | $3,277 | 35.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 14 | $6,090 | $2,120 | 34.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 218 | 241 | $7,229 | $1,620 | 22.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 12 | 12 | $3,468 | $1,412 | 40.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 12 | 16 | $2,432 | $1,214 | 49.9% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 13 | 13 | $4,275 | $1,135 | 26.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 11 | 14 | $2,366 | $1,074 | 45.4% |
| 76376 | 3d radiographic procedure | Facility | 2023 | 84 | 84 | $1,742 | $663.60 | 38.1% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 12 | 12 | $3,576 | $647.22 | 18.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 51 | 54 | $3,618 | $602.10 | 16.6% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 33 | 37 | $1,554 | $437.34 | 28.1% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 20 | 20 | $1,460 | $347.80 | 23.8% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 11 | 12 | $907.00 | $244.08 | 26.9% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 20 | 20 | $980.00 | $232.80 | 23.8% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 18 | 19 | $422.00 | $114.70 | 27.2% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 22 | 23 | $221.00 | $55.67 | 25.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 208 | 869 | $132,957 | $52,315 | 39.3% |
About Dr. Patrick Hourani, M.D
Dr. Patrick Hourani, M.D is a Cardiovascular Disease healthcare provider based in Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/19/2010. The National Provider Identifier (NPI) number assigned to this provider is 1386975175.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Hourani, M.D has received a total of $14,977 in payments from pharmaceutical and medical device companies, with $2,869 received in 2024. These payments were reported across 434 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($14,828).
As a Medicare-enrolled provider, Hourani has provided services to 5,052 Medicare beneficiaries, totaling 9,093 services with total Medicare billing of $633,236. Data is available for 4 years (2020–2023), covering 89 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Miami, FL
- Active Since 01/19/2010
- Last Updated 05/07/2024
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1386975175
Products in Payments
- MYCARELINK (Device) $1,148
- ELIQUIS (Drug) $921.20
- LifeVest (Device) $892.74
- XARELTO (Drug) $721.53
- WATCHMAN Access System (Device) $711.49
- LINQ II (Device) $565.41
- BRILINTA (Drug) $543.61
- JARDIANCE (Drug) $538.67
- WATCHMAN (Device) $493.60
- VERQUVO (Drug) $342.12
- CARDIOBLATE CRYOFLEX (Device) $311.42
- CareLink (Device) $295.73
- CAMZYOS (Drug) $289.93
- VYNDAQEL (Drug) $280.76
- FARXIGA (Drug) $253.01
- FFRct (Device) $229.97
- ENTRESTO (Drug) $228.07
- Resolute (Device) $218.01
- Repatha (Biological) $204.10
- LEQVIO (Drug) $180.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Miami
Theodore Feldman, M.d, M.D
Cardiovascular Disease — Payments: $813,059
Cardiovascular Disease $813,059
Dr. Elliott Elias, Md, Mph, MD, MPH
Cardiovascular Disease — Payments: $337,468
Cardiovascular Disease $337,468
Dr. Sameer Mehta, Md,Facc,Mba, MD,FACC,MBA
Cardiovascular Disease — Payments: $325,786
Cardiovascular Disease $325,786
Dr. Juan Zambrano, Md, MD
Cardiovascular Disease — Payments: $317,068
Cardiovascular Disease $317,068
Dr. Bernard Ashby, Md, MD
Cardiovascular Disease — Payments: $290,680
Cardiovascular Disease $290,680
Mr. Jonathan Fialkow, Md, MD
Cardiovascular Disease — Payments: $251,362
Cardiovascular Disease $251,362